Assessment of Inhalation Hazards

I. Integrative Approach to Assessing Human Health Risk: Two Contemporary Problems.- 1. Integrating Diverse Data Sets to Assess the Risks of Airborne Pollutants.- 2. Risk Assessment for Radon Inhalation Based on Animal Exposure Data and Human Epidemiology.- II. Types of Evidence: General Strengths and Weaknesses.- Section 1. Epidemiological.- 3. Inhalation Hazards: The Interpretation of Epidemiologic Evidence.- 4. Problems in Interpreting Epidemiological Data.- Section 2. Animal.- 5. Rodent Carcinogenicity Studies: Their Value and Limitations.- 6. The Quality and Relevance of Data from Studies in Laboratory Rodents.- Section 3. Dosimetric.- 7. Identification of the Effective Dose of Inhaled Toxicants: General and Specific Problems.- 8. Molecular Dosimetry of Chemical Carcinogens: Implications for Epidemiology and Risk Assessment.- Section 4. Mechanistic.- 9. Pathobiological Effects of Fibers and Tobacco-Related Chemicals in Human Lung Cells in Vitro.- 10. A Mechanistic Approach to Assess the Inhalation Toxicity and Hazard of Methylisocyanate and Related Aliphatic Monoisocyanates.- III. Case Studies.- Section 1. Formaldehyde.- 11. Inhalation Toxicity and Carcinogenicity of Formaldehyde in Animals: Significance for Assessment of Human Health Risk.- 12. Formaldehyde: Evidence of the Carcinogenic Potential from Epidemiological Data.- 13. Covalent Binding of Formaldehyde to DNA: Characterization of Reaction Products and Quantitation Following Inhalation Exposure.- Section 2. Arsenic.- 14. Environmental and Occupational Exposure to Arsenic.- 15. Is Inhaled Arsenic Carcinogenic for Sites Other Than the Lung?.- Section 3. Butadiene.- 16. Toxicology and Carcinogenicity of 1,3-Butadiene.- 17. Species Differences in Pharmacokinetics, Metabolism, and DNA Binding of Inhaled 1,3-Butadiene.- 18. Epidemiologic Data Related to Health Effects of 1,3-Butadiene.- Section 4. Benzene.- 19. A Review of the Toxicokinetics of Benzene.- 20. Benzene Haematotoxicity and Leukaemia.- Section 5.